Clinical Trial Update: AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Only Assessment [NA]

View source ↗

Summary

A completed clinical trial evaluating the LEAP AI-assisted evaluation platform versus clinician-only assessment in acute promyelocytic leukemia and acute myeloi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Promyelocytic Leukemia

Snippet

Sponsor: Harvard Medical School (HMS and HSDM) | Conditions: Acute Promyelocytic Leukemia (APL), Acute Myeloid Leukaemia (AML) | NA | Status: COMPLETED